Related Experiment Video
Updated: Sep 18, 2025
08:22
Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
8.2K
Role of Compensatory miRNA Networks in Cognitive Recovery from Heart Failure
Verena Gisa1,2, Md Rezaul Islam1,2, Dawid Lbik2
1Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Von Siebold Street 3A, 37075 Goettingen, Germany.
Non-Coding RNA
|June 25, 2025
Summary
Heart failure (HF) can impair memory, but microRNA (miRNA) networks in the hippocampus help restore memory function despite ongoing heart problems. This study identifies key miRNAs involved in this memory recovery process.
Area of Science:
- Neuroscience
- Cardiology
- Genetics
Background:
- Heart failure (HF) is linked to cognitive decline and hippocampal dysfunction.
- The molecular basis for these cognitive changes in HF is not fully understood.
- MicroRNA (miRNA) networks may play a role in memory recovery.
Purpose of the Study:
- To investigate the role of hippocampal miRNA networks in memory recovery in a mouse model of HF.
- To identify specific miRNAs involved in restoring hippocampus-dependent memory function.
Main Methods:
- Used CaMKIIδC transgenic mice as an HF model.
- Assessed memory performance through hippocampus-dependent behavioral tasks at 3 and 6 months.
- Analyzed hippocampal miRNA expression using small RNA sequencing and bioinformatic analyses.
Main Results:
- HF mice showed memory deficits at 3 months, which resolved by 6 months despite persistent cardiac dysfunction.
- A dynamic shift in hippocampal miRNA expression was observed, with 27 miRNAs identified as 'compensatory miRs'.
- These compensatory miRNAs targeted most of the dysregulated genes, and miR-181a-5p downregulation correlated with restored memory.
Conclusions:
- miRNA networks facilitate the restoration of hippocampal function and memory in HF, acting as a compensatory mechanism.
- Understanding these miRNA networks could lead to new therapeutic targets for HF-related cognitive dysfunction.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
59
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
01:17Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
01:22Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39
01:27Heart Failure I: Introduction
77
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
77